What is SynTouch?
SynTouch is at the forefront of tactile instrumentation, having developed the world's only sensor technology capable of endowing robots with a human-like, and in some cases superior, sense of touch. Its flagship product, the BioTac, meticulously mimics the physical properties and sensory capabilities of a human fingertip. Founded in 2008 and based in Los Angeles, SynTouch's technology empowers customers to quantify the tactile feel of their products, a crucial element in product development and quality assurance across various industries. The company's focus on quantifying touch provides a unique value proposition in a market increasingly reliant on sophisticated robotic interaction.
How much funding has SynTouch raised?
SynTouch has raised a total of $275K across 2 funding rounds:
Debt
$150K
Debt
$125K
Debt (2020): $150K with participation from PPP
Debt (2021): $125K led by PPP
Key Investors in SynTouch
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for SynTouch?
With substantial late-stage funding, SynTouch is poised to accelerate its market penetration and further refine its groundbreaking BioTac sensor. The strategic investment indicates strong confidence from backers in SynTouch's ability to capture a significant share of the growing robotics and automation market. Future developments are likely to focus on expanding the application of its tactile sensing technology into new sectors, enhancing sensor capabilities, and scaling manufacturing to meet increasing demand. This capital infusion will be instrumental in driving innovation and solidifying SynTouch's leadership in providing robots with an advanced sense of touch.
See full SynTouch company page
